Novavax slips on Report India launch could take longer
[ad_1] By Dhirendra Tripathi Investing.com – Novavax (NASDAQ: NVAX) stock fell 4.2% on Thursday following an article in Indian newspaper Economic Times that said the company’s launch of the company’s Covid-19 vaccine in the country could take more time. According to the report, in the absence of its approval in the United States, the Indian … Read more